Merck & Co.
MRK
Healthcare company manufacturing pharmaceuticals, vaccines, and animal health products
🔒 Volume signal — free with login
🕒 Price Aug 29, 03:17 ET
Grade D · 35/100
💰 Valuation at a glance
Yahoo FinancePrice ÷ EPS. Lower is cheaper vs earnings. Forward-earnings basis.
🎯 Fair-value estimate
OvervaluedCurrent $148.35 — vs fair value +46.4%
※ A theoretical estimate from an objective multiple model — not a price target or a buy/sell recommendation. Investment decisions and responsibility rest with the user.
📊 Price trend
Open in Multi-chart →Yahoo Finance🎯 7-metric analysis
Based on latest annual results
D35 pts
Value axes (P/E, P/B, EV) are growth- & profitability-adjusted — premium growth names aren’t pinned to zero. (Losses / negative equity stay 0.)
📈 Key metrics
Yahoo Finance🏢 Peer comparison
Health CareSide by side with the largest names in the same sector. Green beats the sector median.
| Stock | P/E | P/B | ROE | Dividend |
|---|---|---|---|---|
| Merck & Co.Current | 117.7× | 8.73× | 7.6% | 2.2% |
| Lilly (Eli) | 39.5× | 30.91× | 78.8% | 0.6% |
| Johnson & Johnson |
🏦 Dividend vs deposit rate
This stock's 2.22% dividend is -1.78%p lower than 1Y Treasury yield (4.00%)
⚠️ Unlike a deposit, a dividend comes with principal (price) risk. Even if the yield beats the rate, a falling price can still mean an overall loss. Treat dividend as just one reference metric.
As of: U.S. Treasury Par Yield (1Y) · 4.00% (2026-05)
📡 Technical signals
📊 Mixed moving averages · RSI 63 neutral
Above the moving averages means short-term bullish; below means bearish. RSI ≥ 70 is overbought and ≤ 30 is oversold.
🎮 What if you had bought?
If you'd bought Merck & Co. in the past, what would it be worth now? Play with the period and amount. (For reference · not a buy recommendation)
※ Simple close-price math, excluding fees, taxes and dividends. Past returns don’t guarantee future results.
📰 Related news
Source: Naver Finance (KR) · Yahoo Finance (US) · external article links
💼 Financial statements
Yahoo FinanceRecent annual
| Period | Revenue | Op. income | Net income | Op. margin |
|---|---|---|---|---|
| 2025 FY | $65.01B | $22.11B | $18.25B | 34.0% |
| 2024 FY | $64.17B | $20.22B | $17.12B | 31.5% |
| 2023 FY | $60.12B | $2.95B | $365.0M | 4.9% |
| 2022 FY | $59.28B | $18.28B | $14.52B | 30.8% |
Quarterly results (last 6 quarters)
📚 Metrics & scoringShow moreCollapse
🔎 Data sources & methodologyShow moreCollapse
Every score is auto-computed from the public data below. No manual adjustment.
| Item | Source | Method · update cadence |
|---|---|---|
| Price · volume · 52W | Yahoo Finance | Stored as-is · hourly intraday |
| Financials (revenue, profit, equity, debt) | Yahoo fundamentalsTimeSeries | Annual + quarterly reported · refreshed over ~1 week |
| Short-term (TTM) score | Computed (quarterly financials) | Sum of last 4 quarters + YoY momentum vs same quarter a year ago · daily |
| PER · PBR | Yahoo reported (US) | Yahoo priceToBook · trailingPE |
| Dividend yield | Yahoo Finance | Annual dividend ÷ price · 0% if none |
| ROE · operating margin · debt ratio |